GGrantIndex
← Leaderboards

Gary B. Huffnagle

University Of Michigan At Ann Arbor

$14,751,708
Attributed
$16,639,507
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$16,639,507 · 11

By mechanism

R01$12,915,693 · 7
U19$2,230,388 · 1
R21$836,444 · 2
P30$656,982 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Immune Response

Research focus

Immune ResponseInfectionResponseInflammationMicrobiomeReportingLungInflammatoryPathogenBacteriaLaboratoriesOrganismCytokineMicrobialInflammatory ResponseProductionPathogenesisImmunityPlayDendritic CellsEnvironmentCryptococcus NeoformansLaboratory MouseIndigenous

Grant awards (47)

Neonatal RSV infection and alteration of allergic immune responses$448,066
R01 · FY2022 · AI
Neonatal RSV infection and alteration of allergic immune responses$448,066
R01 · FY2021 · AI
Functional Analysis of the Pulmonary Microbiome during COPD$654,446
R01 · FY2020 · HL · contact PI
Neonatal RSV infection and alteration of allergic immune responses$448,066
R01 · FY2020 · AI
Functional Analysis of the Pulmonary Microbiome during COPD$728,616
R01 · FY2019 · HL · contact PI
Neonatal RSV infection and alteration of allergic immune responses$448,066
R01 · FY2019 · AI
Functional Analysis of the Pulmonary Microbiome during COPD$741,499
R01 · FY2018 · HL · contact PI
Neonatal RSV infection and alteration of allergic immune responses$449,626
R01 · FY2018 · AI
Functional Analysis of the Pulmonary Microbiome during COPD$755,249
R01 · FY2017 · HL · contact PI
Functional Analysis of the Pulmonary Microbiome during COPD$223,216
R01 · FY2017 · HL · contact PI
Pulmonary bacterial microbiome-epithelial cell interactions in COPD$382,189
R01 · FY2015 · HL · contact PI
MICROBIOME AND INFLAMMATION CORE$136,662
P30 · FY2015 · DK · contact PI
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis$441,726
U19 · FY2014 · AI · contact PI
Pulmonary bacterial microbiome-epithelial cell interactions in COPD$380,266
R01 · FY2014 · HL · contact PI
MICROBIOME AND INFLAMMATION CORE$136,660
P30 · FY2014 · DK · contact PI
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis$464,245
U19 · FY2013 · AI · contact PI
Pulmonary bacterial microbiome-epithelial cell interactions in COPD$369,372
R01 · FY2013 · HL · contact PI
MICROBIOME AND INFLAMMATION CORE$109,952
P30 · FY2013 · DK · contact PI
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis$442,418
U19 · FY2012 · AI · contact PI
Pulmonary bacterial microbiome-epithelial cell interactions in COPD$401,882
R01 · FY2012 · HL
MICROBIOME AND INFLAMMATION CORE$141,250
P30 · FY2012 · DK · contact PI
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis$440,298
U19 · FY2011 · AI · contact PI
The Role of the Microbiome in the Development/Prevention of Food Allergies$192,431
R21 · FY2011 · AI · contact PI
MICROBIOME AND INFLAMMATION CORE$132,458
P30 · FY2011 · DK · contact PI
The Interplay Between Host Immunity and Clostridium difficile Pathogenesis$441,701
U19 · FY2010 · AI · contact PI
The Role of the Microbiome in the Development/Prevention of Food Allergies$232,000
R21 · FY2010 · AI · contact PI
Mucosal Mechanisms Linking Pulmonary and Gastrointestinal Inflammation/Immunity$188,837
R21 · FY2010 · AI · contact PI
Role of Fungal Microflora in Mucosal Tolerance/Immunity$351,055
R01 · FY2009 · AI · contact PI
Mucosal Mechanisms Linking Pulmonary and Gastrointestinal Inflammation/Immunity$223,176
R21 · FY2009 · AI · contact PI
Role of Fungal Microflora in Mucosal Tolerance/Immunity$351,055
R01 · FY2008 · AI · contact PI
Role of Oxylipins in Cryptococcal Pathogenesis$310,056
R01 · FY2008 · AI · contact PI
Role of Fungal Microflora in Mucosal Tolerance/Immunity$357,855
R01 · FY2007 · AI · contact PI
Role of Oxylipins in Cryptococcal Pathogenesis$316,060
R01 · FY2007 · AI · contact PI
Role of Fungal Microflora in Mucosal Tolerance/Immunity$368,543
R01 · FY2006 · AI · contact PI
Role of Oxylipins in Cryptococcal Pathogenesis$326,348
R01 · FY2006 · AI · contact PI
Role of Fungal Microflora in Mucosal Tolerance/Immunity$377,412
R01 · FY2005 · AI
Role of Oxylipins in Cryptococcal Pathogenesis$357,590
R01 · FY2005 · AI
Role of Oxylipins in Cryptococcal Pathogenesis$370,840
R01 · FY2004 · AI
MODULATION OF TH1/TH2 RESPONSES BY INNATE IMMUNITY$299,348
R01 · FY2004 · HL
MODULATION OF TH1/TH2 RESPONSES BY INNATE IMMUNITY$299,425
R01 · FY2003 · HL
CHEMOKINE RECEPTORS IN IMMUNITY TO C NEOFORMANS$262,706
R01 · FY2003 · HL
MODULATION OF TH1/TH2 RESPONSES BY INNATE IMMUNITY$299,500
R01 · FY2002 · HL
CHEMOKINE RECEPTORS IN IMMUNITY TO C NEOFORMANS$262,751
R01 · FY2002 · HL
MODULATION OF TH1/TH2 RESPONSES BY INNATE IMMUNITY$299,573
R01 · FY2001 · HL
CHEMOKINE RECEPTORS IN IMMUNITY TO C NEOFORMANS$262,795
R01 · FY2001 · HL
MODULATION OF TH1/TH2 RESPONSES BY INNATE IMMUNITY$300,458
R01 · FY2000 · HL
CHEMOKINE RECEPTORS IN IMMUNITY TO C NEOFORMANS$263,698
R01 · FY2000 · HL